PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

‘Smart needle’ could identify cancer instantly

A new “smart needle” has been developed by scientists to detect cancerous tissue using light.

The researchers, funded by The National Institute for Health Research (NIHR)’s Invention for Innovation programme, created a technology dubbed the “smart needle”, a probe that can identify cancerous tissues or cells “almost instantly.”

The probe works by using a technique called “Raman spectroscopy”, which consists of shining a low power laser onto tissue and measuring the light reflected back. So far the probe has been tested on 68 patient samples in the laboratory, showing it can differentiate between healthy and cancerous tissue.

Made up of fibre-optics encased within a fine needle, the probe can look for cancer under the skin’s surface in areas such as the neck. Healthy tissue gives a different signature of reflected light from cancerous tissue, and research shows it is possible to detect a “fingerprint” of the disease that can be used to spot cancerous tissue in a few seconds.

The smart needle can “measure the molecular changes associated with disease in tissues and cells at the end of the needle. Provided we can reach a lump or bump of interest with the needle tip, we should be able to assess if it is healthy or not,” explained Professor Nick Stone, project lead from the University of Exeter.

The innovative new technique could help speed up cancer diagnosis and reduce the need for diagnostic surgery, particularly in lymphomas, which affect over 15,000 people every year in the UK.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026